PMID: 9438740Jan 23, 1998Paper

Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy

JAMA : the Journal of the American Medical Association
A D FixJ Grant

Abstract

The use of serologic testing to diagnose Lyme disease (LD) is a source of controversy. Expert recommendations also discourage the routine use of antibiotic therapy for prophylaxis of LD following tick bites, but the extent to which physicians in endemic areas have adopted these recommendations is not known. To assess the pattern of use of serologic testing and antibiotic therapy for tick bites and LD and associated charges for management in an endemic area. Active surveillance of patient-physician encounters for tick bites and LD. Primary care practices on the Eastern Shore of Maryland. Consecutive sample of 232 patients with tick bites, LD (defined by physician diagnosis in medical record), and suspected LD (physician notation of possible, but not definite LD) seen in 1995. Serologic testing for LD, test results, antibiotic therapy, and direct costs of management. Surveillance identified 142 patients (61.2%) with diagnoses of tick bites, 40 patients (17.2%) with LD, and 50 patients (21.6%) with suspected LD. Of the 142 patients seen for tick bites, 95 (67%) underwent serologic testing for LD. Of these, 93 patients had initial negative or equivocal results; 24 (26%) of the 93 had convalescent testing, with 1 seroconversion. Sev...Continue Reading

Citations

Jun 1, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison F HinckleyPaul S Mead
May 26, 1999·Emerging Infectious Diseases·M I MeltzerK A Orloski
May 18, 2006·Emerging Infectious Diseases·Xinzhi ZhangAlan D Fix
Jul 20, 1999·Current Opinion in Rheumatology·J Evans
Apr 13, 2010·The Journal of Antimicrobial Chemotherapy·Stephen WarshafskyGary P Wormser
Oct 31, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S EspositoUNKNOWN SITIP Lyme Disease Registry
Jul 17, 2003·Pediatric Case Reviews·Cynthia J Mollen, Louis M Bell
Jul 13, 2002·Arthritis and Rheumatism·Elizabeth C HsiaDaniel A Albert
Jul 14, 2001·The New England Journal of Medicine·E D Shapiro
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E D Shapiro, M A Gerber
Sep 13, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·G P WormserB J Luft
Jun 2, 2000·Seminars in Cutaneous Medicine and Surgery·J W Melski
Feb 26, 2013·Arthritis Care & Research·Jinoos YazdanyUNKNOWN American College of Rheumatology Core Membership Group
Apr 10, 2014·Ticks and Tick-borne Diseases·Meghan E BrettPaul S Mead
May 26, 1999·Annals of Emergency Medicine·J A Edlow
Jan 9, 2004·Clinics in Laboratory Medicine·J Stephen Dumler
Jul 11, 2020·Parasites & Vectors·T Joseph Mattingly, Kalpana Shere-Wolfe
Jun 27, 2001·Postgraduate Medicine·C GoodmanG J Martin
Apr 3, 2003·Scottish Medical Journal·M M DavidsonD O Ho-Yen
May 20, 1998·Postgraduate Medicine·D W Rahn, M W Felz
May 2, 2002·The Medical Clinics of North America·Mary Elizabeth Wilson
May 2, 2002·The Medical Clinics of North America·Jonas Bunikis, Alan G Barbour

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.